NOVC Stock Price, Chart, Stats & News

Novo Nordisk A/S is a global healthcare enterprise that specializes in the discovery, development, production, and worldwide distribution of a comprehensive range of pharmaceutical products. The company's operations are structured around two core segments: diabetes and obesity care, and biopharmaceuticals. Within its diabetes and obesity portfolio, Novo Nordisk provides insulin products, GLP-1 receptor agonists, other protein-based medications such as glucagon, oral anti-diabetic treatments, and related drug delivery systems including needles.